According to our latest research, the global radiation injury drugs market size reached USD 720 million in 2024, driven by increasing incidences of radiation exposure and a heightened focus on public health preparedness. The market is expected to expand at a robust CAGR of 6.8% during the forecast period, projecting a value of USD 1.41 billion by 2033. This growth is primarily fueled by rising cancer therapy procedures involving radiation, ongoing threats of nuclear accidents, and enhanced military preparedness worldwide. https://growthmarketreports.com/report/radiation-injury-drugs-market-global-industry-analysis